Will AbbVie Q2 Global Skyrizi net revenues be above __?

0.3 puan (24s)WeeklyBusiness & Corporate Health & Medicine3g

PolymarketKullanılabilirliği kontrol etKYC yok%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibre

Güncel ima edilen olasılık

$19B 4%+0.1pt

5 seçenek arasında lider

Piyasa kalitesi

49 / 100

Düşük kalite

24s Hacim

₺0

Likidite

₺190,4 B

Orta likidite

Alis / Satis

1.4% / 4.0%

Spread

2.6 pt

Orta spread

7g Değişim

-0.3 pts

Piyasa verileri

13 dakika önce guncellendi

18 Tem 26 20:4331 Tem 26 12:00

Trendler

Sonuç24sOlasılık

Yalnızca sanal bakiye, gerçek para yokYatırım tavsiyesi değildir

Seçilen sonuç

$19B4%

Tutar (USDT)

Kurallar

This market will resolve to "Yes" if AbbVie's Global Skyrizi net revenues for the upcoming second fiscal quarter, as reported in its official company earnings materials, are above the listed amount.

Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials.
Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".

Hacim trendi

$23

19 Tem9g veri27 Tem

İlgili Piyasalar

FDA approves Viatris' low-dose estrogen weekly patch?

₺0

Evet: 74%

POLYMARKET

Chipotle chicken burrito price in July 2026

₺879,9 B

At least $9.75: 99%

KALSHI

Taco Bell Crunchwrap Supreme price in July 2026

₺38,9 B

At least $6.65: 90%

KALSHI

What market cap will STRC reach by July 31?

₺6,7 B

$10B: 49%

POLYMARKET

Price of YSL Y in July 2026?

₺5 B

Above $110.00: 34%

KALSHI

Will Chevron (CVX) Q2 oil-equivalent barrels per day net production (koebd) be above __?

₺947,2

3.9M: 81%

POLYMARKET

Bu konularda aktif

EthereumETH$1,938.21+1.25%

BitcoinBTC$64,828.02+0.15%

SolanaSOL$75.58+0.27%

XRPXRP$1.09-1.20%

BNBBNB$575.07+0.36%

DogecoinDOGE$0.0718-1.22%

İlgili Haberler

Fanatics buys regulated exchange in bid to grow prediction markets businessCoindesk

Cantor is advising crypto bank AMINA on path to potential public listingCoindesk

Bitmine buys more ether as Tom Lee says rising ETH/BTC ratio points to stronger crypto pricesCoindesk

Strategy extends bitcoin pause to five weeks, sells $544.5 million in MSTR as USD reserve hits $3.75 billionThe Block

Michael Saylor's Strategy boosted cash reserve to $3.75 billionCoindesk

LMAX taps Morgan Stanley to weigh $5B sale or Nasdaq listingCrypto News

Kurallar

This market will resolve to "Yes" if AbbVie's Global Skyrizi net revenues for the upcoming second fiscal quarter, as reported in its official company earnings materials, are above the listed amount.

Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials.
Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".

Will AbbVie Q2 Global Skyrizi net revenues be above __?

0.3 puan (24s)WeeklyBusiness & Corporate Health & Medicine3g

PolymarketKullanılabilirliği kontrol etKYC yok%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibre

Güncel ima edilen olasılık

$19B 4%+0.1pt

5 seçenek arasında lider

Piyasa kalitesi

49 / 100

Düşük kalite

24s Hacim

₺0

Likidite

₺190,4 B

Orta likidite

Alis / Satis

1.4% / 4.0%

Spread

2.6 pt

Orta spread

7g Değişim

-0.3 pts

Piyasa verileri

13 dakika önce guncellendi

18 Tem 26 20:4331 Tem 26 12:00

Trendler

Sonuç24sOlasılık

Yalnızca sanal bakiye, gerçek para yokYatırım tavsiyesi değildir

Seçilen sonuç

$19B4%

Tutar (USDT)

Kurallar

This market will resolve to "Yes" if AbbVie's Global Skyrizi net revenues for the upcoming second fiscal quarter, as reported in its official company earnings materials, are above the listed amount.

Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials.
Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".

Hacim trendi

$23

19 Tem9g veri27 Tem

İlgili Piyasalar

FDA approves Viatris' low-dose estrogen weekly patch?

₺0

Evet: 74%

POLYMARKET

Chipotle chicken burrito price in July 2026

₺879,9 B

At least $9.75: 99%

KALSHI

Taco Bell Crunchwrap Supreme price in July 2026

₺38,9 B

At least $6.65: 90%

KALSHI

What market cap will STRC reach by July 31?

₺6,7 B

$10B: 49%

POLYMARKET

Price of YSL Y in July 2026?

₺5 B

Above $110.00: 34%

KALSHI

Will Chevron (CVX) Q2 oil-equivalent barrels per day net production (koebd) be above __?

₺947,2

3.9M: 81%

POLYMARKET

Bu konularda aktif

EthereumETH$1,938.21+1.25%

BitcoinBTC$64,828.02+0.15%

SolanaSOL$75.58+0.27%

XRPXRP$1.09-1.20%

BNBBNB$575.07+0.36%

DogecoinDOGE$0.0718-1.22%

İlgili Haberler

Fanatics buys regulated exchange in bid to grow prediction markets businessCoindesk

Cantor is advising crypto bank AMINA on path to potential public listingCoindesk

Bitmine buys more ether as Tom Lee says rising ETH/BTC ratio points to stronger crypto pricesCoindesk

Strategy extends bitcoin pause to five weeks, sells $544.5 million in MSTR as USD reserve hits $3.75 billionThe Block

Michael Saylor's Strategy boosted cash reserve to $3.75 billionCoindesk

LMAX taps Morgan Stanley to weigh $5B sale or Nasdaq listingCrypto News

Kurallar

This market will resolve to "Yes" if AbbVie's Global Skyrizi net revenues for the upcoming second fiscal quarter, as reported in its official company earnings materials, are above the listed amount.

Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials.
Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".